ICON Reports Fourth Quarter And Full Year 2016 Results Post author:Sam Post published:February 15, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Clarus Ventures Wants To Pick Up The Tab For Big Pharma's R&D With New $910 Million Fund July 17, 2017 Patient Death Forces Alnylam to Suspend Dosing in Hemophilia Trial, Stock Plunges September 6, 2017 Jazz Pharma Announces Offering Of $500 Million Of 1.50% Exchangeable Senior Notes Due 2024 August 17, 2017
Clarus Ventures Wants To Pick Up The Tab For Big Pharma's R&D With New $910 Million Fund July 17, 2017
Jazz Pharma Announces Offering Of $500 Million Of 1.50% Exchangeable Senior Notes Due 2024 August 17, 2017